Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?

Nuclear Medicine Communications

Volumn 34, Issue 8, 2013, Pages 777-786

  Fallahi, Babak ^a   Beiki, Davood ^a   Abedi, Seyed M ^a   Saghari, Mohsen ^a   Fard Esfahani, Armaghan ^a   Akhzari, Fariba ^a   Mokarami, Bahareh ^a   Eftekhari, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Radioiodine therapy; Salivary gland; Thyroid cancer; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; IODINE 131; PERTECHNETIC ACID TC 99M; PLACEBO;

ABLATION THERAPY; ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DOUBLE BLIND PROCEDURE; DRUG UPTAKE; EXCRETION; FEMALE; HUMAN; MALE; PAROTID GLAND; RADIATION INJURY; RADIATION PROTECTION; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND; SALIVARY GLAND FUNCTION; SALIVARY GLAND SCINTISCANNING; SUBMANDIBULAR GLAND; TREATMENT DURATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SALIVARY GLANDS; THYROID NEOPLASMS; VITAMIN E; YOUNG ADULT;

EID: 84879945007     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328362b1f2     Document Type: Article

References (33)

1. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, et al. European Association of Nuclear Medicine (EANM). Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008; 35:1941-1959.
2. American Thyroid Association (ATA), Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167-1214.
3. Firat F, Cermik TF, Sarikaya A, Berkarda S. Effects of gender and age on the quantitative parameters of [99mTc] pertechnetate salivary gland scintigraphy in normal subjects. Nucl Med Commun 2006; 27:447-453.
4. Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 2005; 46:261-266.
5. Ramos FM, Pontual ML, de Almeida SM, Bóscolo FN, Tabchoury CP, Novaes PD. Evaluation of radioprotective effect of vitamin E in salivary dysfunction in irradiated rats. Arch Oral Biol 2006; 51:96-101.
6. Hoelzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, Dudeck J. Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 2000; 27:1465-1472.
7. Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun 2006; 27:495-499.
8. Hyer S, Kong A, Pratt B, Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol) 2007; 19:83-86.
9. Walter MA, Turtschi CP, Schindler C, Minnig P, Müller-Brand J, Müller B. The dental safety profile of high-dose radioiodine therapy for thyroid cancer: longterm results of a longitudinal cohort study. J NuclMed 2007; 48:1620-1625.
10. Grewal RK, Larson SM, Pentlow CE, Pentlow KS, Gonen M, Qualey R, et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. J Nucl Med 2009; 50:1605-1610.
11. Bohuslavizki KH, Klutmann S, Brenner W, Mester J, Henze E, Clausen M. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study. J Clin Oncol 1998; 16:3542-3549.
12. Esfahani AF, Fallahi B, Olamaie R, Eftekhari M, Beiki D, Saghari M. Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment. Hell J Nucl Med 2004; 7:206-209.
13. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003; 189 (1-2):1-20.
14. Bhartiya US, Raut YS, Joseph LJ, Hawaldar RW, Rao BS. Evaluation of the radioprotective effect of turmeric extract and vitamin E in mice exposed to therapeutic dose of radioiodine. Indian J Clin Biochem 2008; 23:382-386.
15. Davies AN, Daniels C, Pugh R, Sharma K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 1998; 12:105-111.
16. Mercadante S, Calderone L, Villari P, Serretta R, Sapio M, Casuccio A, Fulfaro F. The use of pilocarpine in opioid-induced xerostomia. Palliat Med 2000; 14:529-531.
17. Jentzen W, Schneider E, Freudenberg L, Eising EG, Görges R, Müller SP, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun 2006; 27:669-676.
18. Mateos JJ, Setoain X, Ferre J, Rovirosa A, Navalpotro B, Martin F, et al. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours. Nucl Med Commun 2001; 22:651-656.
19. Loutfi I, Nair MK, Ebrahim AK. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance. J Nucl Med Technol 2003; 31:81-85.
20. Helman J, Turner RJ, Fox PC, Baum BJ. 99mTc-pertechnetate uptake in parotid acinar cells by the Na+/K+ /Cl - co-transport system. J Clin Invest 1987; 79:1310-1313.
21. Albrecht HH, Creutzig H. Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy. Rofo 1976; 125:546-551.
22. Ma C, Xie J, Chen Q, Wang G, Zuo S. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer. Cochrane Database Syst Rev 2009; 7:CD007956.
23. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, Tian R. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med 2010; 51:618-623.
24. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Tönshoff G, Sippel C, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun 1996; 17:681-686.
25. UçüncüH, Ertekin MV, Yörük O, Sezen O, Ozkan A, Erdoǧan F, et al. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. J Radiat Res 2006; 47:91-102.
26. Mutlu-Türkoǧlu U, Erbil Y, Oztezcan S, Olgaç V, Toker G, Uysal M. The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci 2000; 66:1905-1913.
27. Yoshimura M, Kashiba M, Oka J, Sugisawa A, Umegaki K. Vitamin E prevents increase in oxidative damage to lipids and DNA in liver of ODS rats given total body X-ray irradiation. Free Radic Res 2002; 36:107-112.
28. Karslioglu I, Ertekin MV, Koçer I, Taysi S, Sezen O, Gepdiremen A, Balci E. Protective role of intramuscularly administered vitamin E on the levels of lipid peroxidation and the activities of antioxidant enzymes in the lens of rats made cataractous with gamma-irradiation. Eur J Ophthalmol 2004; 14:478-485.
29. Felemovicius I, Bonsack ME, Baptista ML, Delaney JP. Intestinal radioprotection by vitamin E (alpha-tocopherol). Ann Surg 1995; 222:504-508, discussion 508-510.
30. Konopacka M, Widel M, Rzeszowska-Wolny J. Modifying effect of vitamins C, E and beta-carotene against gamma-ray-induced DNA damage in mouse cells. Mutat Res 1998; 417 (2-3):85-94.
31. Konopacka M, Rzeszowska-Wolny J. Antioxidant vitamins C, E and beta-carotene reduce DNA damage before as well as after gamma-ray irradiation of human lymphocytes in vitro. Mutat Res 2001; 491 (1-2):1-7.
32. Bhartiya US, Joseph LJ, Raut YS, Rao BS. Effect of Ocimum sanctum, turmeric extract and vitamin E supplementation on the salivary gland and bone marrow of radioiodine exposed mice. Indian J Exp Biol 2010; 48:566-571.
33. Chitra S, Shyamala Devi CS. Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer. Indian J Dent Res 2008; 19:213-218.